# Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

> **NCT05672342** · EARLY_PHASE1 · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Breast Carcinoma
- Chemotherapy-Induced Peripheral Neuropathy
- Colon Carcinoma

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Delta-8-Tetrahydrocannabinol
- **DRUG:** Placebo Administration
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05672342
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-07-06
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05672342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05672342, "Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05672342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*